Physician profile
Brian Parnes
NPI 1336314327
$7,497.39
in general payments reported to CMS, 2019-2025
34 companies · $1,492 in 2025
The $1,492 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $345 · 2020: $761 · 2021: $1,117 · 2022: $875 · 2023: $1,187 · 2024: $1,720 · 2025: $1,492.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,214 · Education: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,213.58 |
| Education | $185.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,879.31 | 2019-2025 | Lithovue, Rezum Generator, Ams 700 |
| Coloplast Corp | $1,094.86 | 2020-2025 | Titan |
| Procept Biorobotics Corporation | $858.44 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Axonics, INC. | $646.85 | 2022-2024 | Axonics, Bulkamid |
| Janssen Biotech, INC. | $390.73 | 2019-2025 | Erleada |
| Dornier Medtech America, INC | $311.70 | 2025 | Dornier Medtech |
| Endo Pharmaceuticals INC. | $309.47 | 2019-2022 | |
| Teleflex LLC | $287.80 | 2021-2025 | Barrigel, Urolift |
| Astellas Pharma US INC | $268.77 | 2019-2024 | Xtandi, Myrbetriq |
| Allergan, INC. | $229.79 | 2019-2021 | |
| Pfizer INC. | $141.72 | 2020-2023 | |
| Abbvie INC. | $93.90 | 2022-2024 | |
| Lumenis, INC | $93.25 | 2021 | |
| Myovant Sciences INC. | $84.81 | 2021-2022 | |
| Tolmar Pharmaceuticals, INC. | $84.54 | 2020-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| C. R. Bard, INC. & Subsidiaries | $75.23 | 2023-2025 | Bard Urinary Drainage Bag |
| Dentsply Ih INC. | $69.43 | 2019-2021 | |
| Myriad Genetic Laboratories, INC. | $68.56 | 2021-2022 | |
| Urogen Pharma, INC. | $58.76 | 2022-2025 | Jelmyto |
| Accord Healthcare, INC. | $56.77 | 2022-2023 | |
| Ambu INC. | $55.68 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $47.17 | 2022-2023 | Keytruda, Lynparza |
| Karl Storz Endoscopy-America | $46.74 | 2020-2024 | Hopkins |
| Mckesson Medical-Surgical, INC. | $46.62 | 2024 | |
| Endo USA, INC. | $31.47 | 2024-2025 | Xiaflex |
| Dendreon Pharmaceuticals LLC | $26.09 | 2021 | |
| 180 Medical, INC. | $24.19 | 2022 | |
| Neotract INC. | $19.73 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $18.46 | 2022 | |
| Urovant Sciences INC | $17.57 | 2022 | |
| Tolmar, INC. | $17.16 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $16.00 | 2022 | |
| Sumitomo Pharma America, INC. | $14.43 | 2023 | Gemtesa |
| Photocure INC | $11.39 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Parnes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.